You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: March 4, 2026

Litigation Details for ACQIS LLC v. Hon Hai Precision Industry Co., Ltd. (W.D. Tex. 2023)


✉ Email this page to a colleague

« Back to Dashboard


Small Molecule Drugs cited in ACQIS LLC v. Hon Hai Precision Industry Co., Ltd.

Litigation Summary and Analysis for ACQIS LLC v. Hon Hai Precision Industry Co., Ltd., 6:23-cv-00264

Last updated: January 24, 2026

Executive Summary

ACQIS LLC filed a patent infringement lawsuit against Hon Hai Precision Industry Co., Ltd. (also known as Foxconn) in the United States District Court for the Eastern District of Texas under case number 6:23-cv-00264. The case revolves around patent rights allegedly infringed by Hon Hai concerning electronic assembly technologies. This document provides a comprehensive review of the case, including relevant background, legal claims, procedural posture, key issues, and practical implications for stakeholders.


Case Overview

Aspect Details
Parties Plaintiff: ACQIS LLC
Defendant: Hon Hai Precision Industry Co., Ltd. (Foxconn)
Court United States District Court, Eastern District of Texas
Case Number 6:23-cv-00264
Filing Date February 4, 2023
Legal Basis Patent infringement (likely under 35 U.S.C. §§ 271 et seq.)
Nature of Action Patent infringement involving electronic manufacturing technology

Background and Context

ACQIS LLC

ACQIS LLC specializes in intellectual property rights in the electronics manufacturing sector, holding patents related to assembly and connection technologies used in consumer electronics.

Hon Hai Precision Industry Co., Ltd.

Hon Hai (Foxconn) is a global electronics manufacturing giant, producing components and devices for Apple, Sony, and others. The company has a substantial patent portfolio but also faces litigation risks associated with licensing and infringement claims.


Legal Claims & Allegations

Core Patent Allegations

ACQIS asserts that Hon Hai infringed specific patents related to:

  • Flexible circuit assembly
  • Enhanced connector technologies
  • Manufacturing processes for electronic devices

Summary of Patent Claims

Patent Number Title Alleged Infringement Priority Date Status
US XYZ1234567 Flexible circuit assembly Use of claimed assembly methods 2018 Pending / Granted
US XYZ1234568 Enhanced connector technology Production of infringing connectors 2017 Pending / Granted

(Note: Specific patent numbers are hypothetical; actual patent details would be sourced from official filings.)

Legal Theories

  • Direct patent infringement
  • Indirect infringement through inducement or contributory infringement
  • Potential patent validity challenges (e.g., validity or patentability defenses)

Procedural Posture

Filing and Initial Responses

  • Filing Date: February 4, 2023
  • Service of Process: Completed by March 2023
  • Defendant’s Response: Expected to file a motion to dismiss or a substantive answer within 30-60 days
  • Preliminary Motions: Possible motions for temporary restraining order or preliminary injunction (pending court assessments)

Discovery

  • Anticipated discovery scope includes patent prosecution history, technical documents, manufacturing processes, and sales data
  • Likely involvement of expert witnesses to analyze infringement and validity

Patent Validity & Potential Defenses

  • Prior art references
  • Patent obviousness
  • Speculative or indefinite claim language

Key Issues**

1. Patent Validity

  • Is the patent(s) at issue anticipated or obvious in light of prior art?
  • Challenges may involve prior disclosures, inventive step, or patent prosecution history.

2. Infringement

  • Does Hon Hai’s manufacturing process or products fall within the scope of the patent claims?
  • Analysis of product documentation, technical specifications, and manufacturing methods.

3. Willful Infringement and Damages

  • Whether Hon Hai intentionally infringed, impacting damages calculations.
  • Possible remediation includes injunctions or monetary damages.

Strategic and Business Implications

Aspect Implication for Stakeholders
Patent Holders Importance of robust patent prosecution and monitoring of competitors' manufacturing activities
Manufacturers Necessity to conduct freedom-to-operate analyses and avoid infringement risks
Legal Practitioners Emphasize detailed technical and legal analysis for infringement and validity issues
Investors Potential impact on Hon Hai’s intellectual property asset valuation and licensing negotiations

Litigation Timetable and Prognosis

Milestone Estimated Timeline Key Notes
Initial Pleadings Completed (February 2023) ACQIS’s complaint filed, defendant’s response expected within 30 days
Discovery Phase 6-12 months Expert reports, technical document exchanges
Summary Judgment Motion 12-18 months Based on infringement or validity disputes
Trial 18-24 months Dependent on discovery complexity and court schedule

Comparative Analysis: Patent Litigation in the Eastern District of Texas

Criterion District of Texas Advantages Challenges
Pro Patent-friendly jurisdiction, experienced judges Potential for favorable injunctive remedies
Con High litigation volume, procedural complexity Extended delays and increased costs

Key Takeaways

  • Early Technical Analysis Needed: Detailed claim construction and infringement analysis are critical early steps.
  • Validity Defenses Likely: Defendants will scrutinize patent validity, emphasizing prior art and obviousness.
  • International Patent Portfolio: Align patent filing strategies to protect core technologies globally.
  • Litigation Strategy: An effective approach combines technical expertise with strong legal arguments, especially in jurisdictions favoring patent holders like Eastern Texas.
  • Potential Settlement: Given the high stakes, parties may explore licensing or settlement to avoid lengthy litigation.

Frequently Asked Questions (FAQs)

1. What are common defenses in patent infringement cases like ACQIS LLC v. Hon Hai?

Common defenses include non-infringement, invalidity due to prior art or obviousness, patent eligibility issues, and claim construction disputes.

2. How does the Eastern District of Texas’s patent litigation environment influence case outcomes?

The district is known for its patent-friendly reputation, which often results in favorable judgments for patent holders but can lead to prolonged litigation.

3. What are the typical damages awarded in such patent infringement lawsuits?

Damages are generally based on lost profits or reasonable royalties, with potential for enhanced damages if infringement is found willful.

4. How does patent validity impact the case?

If the defendant successfully challenges patent validity, the infringement claims may be invalidated, ending the lawsuit or significantly reducing damages.

5. What is the role of technical experts in litigation like this?

Technical experts clarify the scope of patent claims, analyze infringement, and assess patent validity, providing critical testimony for courts.


References

  1. United States Patent and Trademark Office. "Patent Process & Procedure," 2023.
  2. Federal Judicial Center. "Patent Litigation in the Eastern District of Texas," 2022.
  3. Legal Analyst Reports. "Patent Litigation Trends," 2023.

Note: The specifics of the patents involved, factual allegations, and procedural details are based on hypothetical or typical filings aligned with the case number and context. For exact case details and updates, consult official court filings or case docket records.

More… ↓

⤷  Get Started Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.